
Cardiac D-Dimer Rapid Test Kits for Fluorescence Immunoassay
Brand :Norman
Product origin :China
Delivery time :In one month
Supply capacity :1, 000, 000.00/Month
Quick read D-Dimer test kits:
Methodology: Fluorescence Immunoassay
D-dimer is a product of fibrin clot digestion and therefore is an indicator of recent or current clot formation and lysis.
D-Dimer:
1. Negative exclusion indicator of venous thromboembolism.
2. High sensitivity, VTE negative predictive value ≥99%.
3. D-dimer is a product of fibrin clot digestion and therefore is an indicator of recent or
current clot formation and lysis.
4. It is the most frequently used marker of coagulation and fibrinolysis.
Quick read D-Dimer test kits:
Methodology: Fluorescence Immunoassay
D-Dimer:
1. Negative exclusion indicator of venous thromboembolism.
2. High sensitivity, VTE negative predictive value ≥99%.
3. D-dimer is a product of fibrin clot digestion and therefore is an indicator of recent or
current clot formation and lysis.
4. It is the most frequently used marker of coagulation and fibrinolysis.
Clinical Utility Of The D-dimer Assay:
1. The utility of the assay lies in its negative predictive value since a high D-dimer is a
non-specific finding. A negative result (D-dimer concentration below the cut-off) can
be used to assist in the exclusion of VTE in certain patient populations.
2. D-dimer testing is often utilized in a diagnostic algorithm which combines clinical decision
rules and imaging studies. If the clinical decision rule categorizes a patient as low or unlikely
to have VTE and the patient has a negative D-dimer test (using a sensitive assay), then the
diagnosis is excluded.
Clinical Significance:
1. Deep vein thrombosis (DVI) and exclusion diagnosis of pulmonary embolism(PE).
2. Diagnosis of disseminated intravascular coagulation(DIC).
3. Effective detection and evaluation indicator of thrombolytic effect.
4. Condition evaluation of cardiovascular disease.
5. Identification and treatment detection of cerebral infarction.
Applicable department:
ICU, outpatient emergency, surgery, respiration, cardiology, internal medicine-
neurology, geriatric, oncology, gynecology.
Product Advantage:
1. High sensitivity:0.1mg/l.
2. Convenient use: test card is aluminum foil bag for 1 person per bag, test immediately
when patient comes.
3. Small sample size: 30ul (plasma).
4. High accuracy: 99% correlation with Siemens D-Dimer.
5. Wide linear range:0.1-10mg/l.
Performance Analysis:
1. Correlation analysis between Norman D-Dimer and Siemens D-Dimer European society of Cardiology
Guidelines for the diagnosis and treatment of acute pulmonary embolism.
2. Recommend to use D-Dimer test as the screening indicator of pulmonary embolism
diagnosis in emergency department.
3. Clinical and laboratory standards institute.
4. H59-P guideline: In low and middle clinical risk peak, D-Dimer quantitative test is used
for exclusion diagnosis of venous thrombus embolism(VET).
Intended Use
The test kit is mainly for the in vitro quantitative determination of D-Dimer in human plasma.
D-Dimer is a good index of active cellulose dissolution. It is of diagnosis value in diseases
caused by thrombosis such as disseminated intravascular coagulation (DIC), deep vein thrombosis,
pulmonary embolism, cerebrovascular disease, liver disease, acute myocardial infarction after the surgery,
gynecology, pediatrics and other diseases. At the same time, D-Dimer detection can also be used as an index
in the treatment of thrombolytic drug.
Test Principle
The reagent is based on immunofluorescence sandwich assay to detect D-Dimer concentrations quantitatively.
Add the sample to the sample well of the cartridge. Through chromatography sample reacts with the fluorescent
latex particles coated with D-Dimer monoclonal antibody I on the conjugate pad. The complex spread ahead
along the nitrocellulose membrane captured by D-Dimer monoclonal antibody II on the test line.The more
D-Dimer the sample contains, the more complexes the test line accumulates. The intensity of fluorescent
antibody signal reflects the amount of captured D-Dimer. Immunofluorescence quantitative analyzer produced
by our company can detect the concentration of D-Dimer in the sample.
Related products
Package & Delivery:
Inflammation/Infection: PCT(whole blood), PCT (surum), hs-CRP
Cardiovascular: NT-proBNP, D-Dimer cTnI,CK-MB, MYO
Nephropathy: NAGL, RBP,Cys-c, mAlb, B2-MG
Gastrosis: PGⅠ/ PGⅡ/ PGR/ HP/ FOB
Rheumatism:RF
Diabetes:C-Peptide
About us:
Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing
of automated chemiluminescence system. Founded in 2008, Norman biological has been
upholding the idea that R&D shapes future ,and concentration determines success. Ever
since the beginning, Norman has been focusing on developing and manufacturing
chemiluminescence instruments and reagents.
Norman's manufacture center is located in the Yuhua District and owns an over 2,000m2
GMP-approved clean workshop. The R&D base, which is over 2,000m2 , is located in state-
level new Jiangbei district. Now there are over 100 R&D engineers, 40% of which hold a
PhD or master's degree.
Powered by advanced technology and excellent talents in the IVD field, Norman has been
consistently improving its innovation platform , and increasing R&D investment. Self-
innovation, combined with long-term strategic cooperation with universities and research
institutes and with outsourced technologies, ensures consistent improvement on product
quality. Norman's R&D field has covered instruments, reagents, and raw materials, and
has been entrusted by the Nanjing government to build a R&D center specialized in
biological chemistry and immunity diagnosis. Up to now, Norman has acquired over 20 patents.
Being an expert in automated chemiluminescence analysis , Norman owns independent
and completed intellectual property rights, and its products provide top-notch sensitivity,
precision and accuracy . Thanks to the self-developed antigens and self-manufactured
antibodies, Norman's products features minimized intra-and inter-batch difference.
After 8 years development, Norman is now on the fast track. An over 30,000m2 global
R&D center is in construction, and will hold more than 1,000 R&D engineers in the future.
R&D shapes future, and concentration determines success. Driven by the commitment to
"provide complete solution to improve human health", Norman will consistently do its
utmost to drive the IVD industry forward and contribute more to human health.
Agent Wanted:If you are interested in working with us, please feel free to contact.